DEPRESCRIBING – A NECESSARY DISCUSSION FOR THE INTEGRAL HEALTH OF THE ELDERLY
PDF (Inglês)
PDF

Palavras-chave

polypharmacy; continuous use medications; health of the elderly.

Como Citar

Scremin, M. ., Carl Silva, J. ., Henrique Pereira Sena, K. ., Carpegiane Ornelas Deles, B. ., Alencar Froes, K. ., Sérgio David de Castro, P. ., Gusmão Soares, R. ., Ribeiro de Andrade Neto, G. ., Veloso Quintino Borborema, F., Falcão de Ornelas, H. ., Mendes de Oliveira, J. ., Kariny Soares Oliveira, M. ., Caroline Oliveira de Souza Boitrago, S. ., Antunes Aquino Cardoso Gonçalves, S. ., Luíza Leobas Moreira Nogueira, A. ., Diniz Rabelo Lopes, V. ., & de Oliveira Monteiro, M. . (2026). DEPRESCRIBING – A NECESSARY DISCUSSION FOR THE INTEGRAL HEALTH OF THE ELDERLY. Health and Society, 6(01), 72-82. https://doi.org/10.51249/hs.v6i01.2975

Resumo

The present study aims to understand the deprescribing process among elderly patients. A theoretical-reflective study was conducted based on the concepts of health education and health promotion. In the face of technological advances in the health area, increased income, urbanization and many other social advances that culminated in the increase in the life expectancy of the population, another synergistic phenomenon was the epidemiological transition, causing an increase in the number of chronic-non-communicable diseases, requiring health services and professionals to act effectively and comprehensively in the face of this new paradigm in population health.  In this sense, medications are an important support strategy, however, when this use is unsystematic, exaggerated and indiscriminate, it can substantially harm the health of the elderly, in this discussion, deprescription presents itself as an important clinical tool to reduce the health risks of these individuals, however, there are barriers of training, resistance of family members and professionals,  Because the latter are often trained in a biologist and curative model, in a logic that for each complaint a drug is chosen, thus, efforts are needed from the country’s training bodies to train professionals who are committed to presenting other possibilities to patients, which often bring less risk and better clinical outcomes.

PDF (Inglês)
PDF

Referências

ALHARTHI, M. et al. Barriers and enablers to deprescribing for older people in care homes: the theory-based perspectives of pharmacist independent prescribers. Research in Social and Administrative Pharmacy, v. 19, n. 5, p. 746-752, 2023.

BALDONI, A. D. O. et al. Elaboration and validation of the clonazepam deprescribing protocol in the elderly. Brazilian Journal of Family and Community Medicine, v. 15, n. 42, p. 2105, 2020.

CORREIA, W.; TESTON, A. P. M. Aspects related to polypharmacy in the elderly: a review study. Brazilian Journal of Development, v. 6, n. 11, p. 93454-93469, 2020.

DONIS, A. C. G.; OLIVEIRA, H. S. B.; SOUSA, J. R. P. Potentially inappropriate drug prescription (PMPI): application of the 2015 Beers criteria in a group of elderly people in the supplementary health sector. São Paulo: Centro Universitário São Camilo, 2017.

ELBEDDINI, A. et al. Barriers to conducting deprescribing in the elderly population amid the COVID-19 pandemic. Research in Social and Administrative Pharmacy, v. 17, n. 1, p. 1942-1945, 2021.

GARFINKEL, D.; ILHAN, B.; BAHAT, G. Routine deprescribing of chronic medications to combat polypharmacy. Therapeutic Advances in Drug Safety, v. 6, n. 6, p. 212-233, 2015.

GOYAL, P. et al. Patient-reported barriers and facilitators to deprescribing cardiovascular medications. Drugs & Aging, v. 37, n. 2, p. 125-135, 2020.

GRAÇA, C.; GONÇALVES, P. I. C. End-of-life infection: is there a benefit from antibiotic therapy? Medicina Interna, v. 26, n. 4, p. 335-339, 2019.

KADAM, U. T. Potential health impacts of multiple drug prescribing for older people: a case-control study. Journal of the Royal College of General Practitioners, v. 61, n. 583, p. 128-130, 2011.

LEE, J. Y.; FARRELL, B.; HOLBROOK, A. M. Deprescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines. Polish Archives of Internal Medicine, v. 129, n. 1, p. 43-49, 2019.

LIM, L. M. et al. Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multiethnic Malaysia. PLoS One, v. 12, n. 3, p.e0173466, 2017.

MASNOON, N. et al. What is polypharmacy? A systematic review of definitions. BMC Geriatrics, v. 17, n. 1, p. 230-239, 2017.

MENEGHEL, M.; MARTIGNAGO, N.; KOCK, K. S. Analysis of accessibility in basic health units in Tubarão-SC. Journal of Physiotherapy and Rehabilitation, v. 1, n. 1, p. 42-51, 2017.

MINAYO, M. C. S. (ed.). Social research: theory, method and creativity. 18. ed. Petrópolis: Vozes, 2014.

MINISTRY OF HEALTH (BR); CONCEIÇÃO HOSPITAL GROUP. Clinical guidelines/care protocols. Porto Alegre: Operational Manual, 2008.

MORTAZAVI, S. S. et al. Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open, v. 6, n. 3, p.e010989, 2016.

OLIVEIRA, P. C. de et al. Prevalence and factors associated with polypharmacy in elderly patients treated in primary health care in Belo Horizonte-MG, Brazil. Ciência & Saúde Coletiva, v. 26, n. 4, p. 1553-1564, 2021.

OKTORA, M. P. et al. Attitudes towards deprescribing and patient-related factors associated with willingness to stop medication among older patients with type 2 diabetes in Indonesia. BMC Geriatrics, v. 23, n. 1, p.90-99, 2023.

PARR, J. M. et al. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction, v. 104, n. 1, p. 13-24, 2009.

POTTIE, K. et al. Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Canadian Family Physician, v. 64, n. 5, p. 339-351, 2018.

RIBOLIS, I. P. et al. Frequency of polypharmacy in elderly people assisted by pharmaceutical residents. PECIBES, v. 2, p. 85-101, 2018.

RODRIGUES, D. S. et al. Impacts caused by polypharmacy on the elderly: an integrative review. Research, Society and Development, v. 10, n. 2, p.e28810212263, 2021.

ROMERO, I. “Deprescribe” in end-of-life patients: a guide to improve clinical practice. Medicina Interna, v. 25, n. 1, p. 48-57, 2018.

SCOTT, I. A. et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Internal Medicine, v. 175, n. 5, p. 827-834, 2015.

THERRIEN, J. New contexts of graduate education In: ENCONTRO DE PESQUISA EDUCACIONAL DO NORTE E NORDESTE (EPENN), 22., 2014, Natal. Annals [...]. Natal: [s.n.], 2014.

ZECHMANN, S. et al. Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care: a cluster-randomised clinical trial. BMC Geriatrics, v. 20, n. 1, p.100-110, 2020.

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.

Copyright (c) 2026 Marlete Scremin, Jean Carl Silva, Kaio Henrique Pereira Sena, Bruno Carpegiane Ornelas Deles, Karine Alencar Froes, Paulo Sérgio David de Castro, Raquel Gusmão Soares, Gregório Ribeiro de Andrade Neto, Francine Veloso Quintino Borborema, Haline Falcão de Ornelas, Jaqueline Mendes de Oliveira, Maricy Kariny Soares Oliveira, Sarah Caroline Oliveira de Souza Boitrago, Sueli Antunes Aquino Cardoso Gonçalves, Ana Luíza Leobas Moreira Nogueira, Vanusa Diniz Rabelo Lopes, Marivone de Oliveira Monteiro